BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Staging
19 results:

  • 1. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]    [Full Text] [Related]  

  • 2. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
    Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
    Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role of lymphadenectomy during primary surgery for kidney cancer.
    Bekku K; Kawada T; Yanagisawa T; Karakiewicz PI; Shariat SF
    Curr Opin Urol; 2023 Jul; 33(4):294-301. PubMed ID: 37014778
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
    Boulenger de Hauteclocque A; Ferrer L; Ambrosetti D; Ricard S; Bigot P; Bensalah K; Henon F; Doumerc N; Méjean A; Verkarre V; Dariane C; Larré S; Champy C; de La Taille A; Bruyère F; Rouprêt M; Paparel P; Droupy S; Fontenil A; Patard JJ; Durand X; Waeckel T; Lang H; Lebâcle C; Guy L; Pignot G; Durand M; Long JA; Charles T; Xylinas E; Boissier R; Yacoub M; Colin T; Bernhard JC
    BJU Int; 2023 Aug; 132(2):160-169. PubMed ID: 36648124
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Progression of Chronic kidney Disease Following Radical and Partial Nephrectomy.
    Britton CJ; Sharma V; Lohse CM; Lieske JC; Nichols PE; Khanna A; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH; Potretzke AM
    Urology; 2022 Nov; 169():125-133. PubMed ID: 35878813
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pre-surgical chronic kidney disease continues to drive outcomes in the modern era of minimally invasive renal surgery, despite advances in technology.
    Omil-Lima D; Gupta K; Weinstein I; Kent M; Shoag J; Sheyn D; Lengu I
    Int Urol Nephrol; 2022 Jan; 54(1):1-7. PubMed ID: 34837574
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Temporal improvements in renal surgery outcomes across surgical approaches.
    Gupta K; Omil-Lima D; Sheyn D; Shoag J
    Int Urol Nephrol; 2021 Jul; 53(7):1311-1316. PubMed ID: 33591487
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis staging Criteria.
    Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
    Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software.
    Zhuang W; Chen J; Li Y; Liu W
    Int Urol Nephrol; 2020 Feb; 52(2):253-262. PubMed ID: 31612422
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.
    Rieken M; Boorjian SA; Kluth LA; Capitanio U; Briganti A; Thompson RH; Leibovich BC; Krabbe LM; Margulis V; Raman JD; Regelman M; Karakiewicz PI; Rouprêt M; Abufaraj M; Foerster B; Gönen M; Shariat SF
    World J Urol; 2019 Aug; 37(8):1631-1637. PubMed ID: 30406477
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
    Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
    Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis.
    Srivastava A; Patel HD; Joice GA; Semerjian A; Gorin MA; Johnson MH; Allaf ME; Pierorazio PM
    Urol Oncol; 2018 Jan; 36(1):12.e7-12.e13. PubMed ID: 28970053
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Surgical strategy of bilateral synchronous sporadic renal cell carcinoma-experience of a Chinese university hospital.
    Hu XY; Xu L; Guo JM; Wang H
    World J Surg Oncol; 2017 Feb; 15(1):53. PubMed ID: 28245846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
    Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
    J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy.
    Lee KH; Chen YT; Chung HJ; Liu JS; Hsu CC; Tarng DC
    Ren Fail; 2016; 38(1):77-83. PubMed ID: 26513686
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor.
    Cost NG; Lubahn JD; Granberg CF; Schlomer BJ; Wickiser JE; Rakheja D; Gargollo PC; Leonard D; Raj GV; Baker LA; Margulis V
    Pediatr Blood Cancer; 2012 Jun; 58(6):898-904. PubMed ID: 21744482
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Should hilar lymph nodes be expected in radical nephrectomy specimens?
    Phan DC; McKenney JK; Cox RM; Madi R; Greene GF; Gokden N
    Pathol Res Pract; 2010 May; 206(5):310-3. PubMed ID: 20189726
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The number of lymph nodes examined and staging accuracy in renal cell carcinoma.
    Terrone C; Guercio S; De Luca S; Poggio M; Castelli E; Scoffone C; Tarabuzzi R; Scarpa RM; Fontana D; Rocca Rossetti S
    BJU Int; 2003 Jan; 91(1):37-40. PubMed ID: 12614247
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.